Skip to content

Author

M. Lanza

We have 2 of 126 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

RIPK1 in Alzheimer’s Disease: A Context-Dependent Signaling Hub Linking Aβ, Tau, Neuroinflammation, and Regulated Cell Death

It is proposed that RIPK1 is an understudied pathway in Alzheimer’s disease pathogenesis and that defining its cell-type-specific and stage-dependent functions will be essential to determine whether RIPK1 inhibition can be developed as a disease-modifying therapeutic strategy.

Antonella Caccamo, M. Lanza, G. Casili et al. · 0 citations
Open access Jan 2026

Tempol Ameliorates Psoriatic Skin Inflammation: Evidence of TLR4/NF‐κB/Nrf2 Axis Modulation

Tempol preserved tissue viability under psoriasiform conditions and significantly reduced Staphylococcus aureus (S. aureus) adhesion, and restored epidermal barrier integrity, as demonstrated by increased levels of tight junction and differentiation markers, even under infection‐associated conditions.

S. Scuderi, M. Lanza, A. Capra et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.